NZ335531A - Composition and methods of producing human cartilage tissue - Google Patents
Composition and methods of producing human cartilage tissueInfo
- Publication number
- NZ335531A NZ335531A NZ335531A NZ33553197A NZ335531A NZ 335531 A NZ335531 A NZ 335531A NZ 335531 A NZ335531 A NZ 335531A NZ 33553197 A NZ33553197 A NZ 33553197A NZ 335531 A NZ335531 A NZ 335531A
- Authority
- NZ
- New Zealand
- Prior art keywords
- chondrocytes
- cartilage tissue
- composition
- methods
- producing human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3654—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Wood Science & Technology (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Physical Education & Sports Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The isolation and use of pre-chondrocytes from the umbilical cord, specifically from Wharton's jelly, that give rise to chondrocytes that produce cartilage tissue. The isolated pre-chondrocytes, or the chondrocytes to which they give rise, can be mitotically expanded in culture and used in the production of new cartilage tissue for therapeutic use. "Banks" of pre-chondrocytes or chondrocytes can be stored frozen, and thawed and used to produce new cartilage tissue as needed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/735,620 US5919702A (en) | 1996-10-23 | 1996-10-23 | Production of cartilage tissue using cells isolated from Wharton's jelly |
PCT/US1997/018862 WO1998017791A1 (en) | 1996-10-23 | 1997-10-23 | Production of cartilage tissue using cells isolated from wharton's jelly |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ335531A true NZ335531A (en) | 2000-09-29 |
Family
ID=24956535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ335531A NZ335531A (en) | 1996-10-23 | 1997-10-23 | Composition and methods of producing human cartilage tissue |
Country Status (8)
Country | Link |
---|---|
US (1) | US5919702A (en) |
EP (1) | EP0939803A1 (en) |
JP (1) | JP2001502905A (en) |
KR (1) | KR20000052709A (en) |
AU (1) | AU731827B2 (en) |
CA (1) | CA2269121A1 (en) |
NZ (1) | NZ335531A (en) |
WO (1) | WO1998017791A1 (en) |
Families Citing this family (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6528483B2 (en) | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
US20050043234A1 (en) | 1996-10-16 | 2005-02-24 | Deisher Theresa A. | Novel FGF homologs |
US6613278B1 (en) * | 1998-11-13 | 2003-09-02 | Regeneration Technologies, Inc. | Tissue pooling process |
DE19752900A1 (en) * | 1997-11-28 | 1999-06-02 | Biotechnolog Forschung Gmbh | Bone matrix and / or osteogenic cells, their use, therapeutic preparation and kit |
US6066495A (en) * | 1998-03-05 | 2000-05-23 | Tissue Engineering, Inc. | Methods and apparatus for the conditioning of ligament replacement tissue |
US6637437B1 (en) * | 1998-04-08 | 2003-10-28 | Johns Hopkins University | Cell-culture and polymer constructs |
DE19835368C1 (en) * | 1998-08-05 | 2000-02-10 | Juergen Steinmeyer | Process for the preparation of a cartilage cell suspension |
ATE311437T1 (en) * | 1998-09-18 | 2005-12-15 | Massachusetts Inst Technology | USE OF GROWTH FACTORS AND HORMONES TO PRODUCE HUMAN CHONDROCYTES AND CARTILAGE TISSUE PRODUCTION |
DE20023640U1 (en) * | 1999-10-06 | 2005-06-23 | Tigenix N.V. | Detecting an embryonic cell surface marker e.g. cartilage-derived morphogenic protein CDMP-1 so as to positively identify viable precursor cells that have entered a post-natal differentiation pathway |
EP1099443A1 (en) | 1999-11-11 | 2001-05-16 | Sulzer Orthopedics Ltd. | Transplant/implant device and method for its production |
WO2001035968A1 (en) * | 1999-11-19 | 2001-05-25 | Children's Medical Center Corporation | Methods for inducing chondrogenesis and producing de novo cartilage in vitro |
US20020041900A1 (en) * | 2000-05-01 | 2002-04-11 | Ole Olsen | Chondrocyte cultures and fractions therefrom |
ATE308610T1 (en) | 2000-05-31 | 2005-11-15 | Fraunhofer Ges Forschung | THREE-DIMENSIONAL SKIN MODEL |
AU2001280164A1 (en) * | 2000-08-28 | 2002-03-13 | Osteogenesis Co., Ltd. | Medicinal compositions for forming tissue around bone or tooth, process for preparing the same, injections for forming tissue around bone or tooth and process for preparing the same |
WO2002046373A1 (en) | 2000-12-06 | 2002-06-13 | Hariri Robert J | Method of collecting placental stem cells |
JP2002233567A (en) * | 2000-12-06 | 2002-08-20 | Mitsuo Ochi | Tissue equivalent for transplantation and its method of manufacture |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
EP2316919B1 (en) * | 2001-02-14 | 2015-10-07 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
ES2558626T3 (en) * | 2001-02-14 | 2016-02-05 | Anthrogenesis Corporation | Placenta post-partum of mammals, their use and placental stem cells thereof |
US20070082052A1 (en) * | 2001-02-23 | 2007-04-12 | Bonassar Lawrence J | Tympanic membrane repair constructs |
WO2002067812A2 (en) * | 2001-02-23 | 2002-09-06 | University Of Massachusetts | Tympanic membrane patch |
AU2002252025A1 (en) | 2001-02-23 | 2002-09-12 | University Of Massachusetts | Injection molding of living tissues |
FR2821853B1 (en) * | 2001-03-09 | 2003-05-16 | Natural Implant Sa | BIOREACTOR FOR THIN FILM CULTIVE TISSUE AND USES |
KR100494265B1 (en) * | 2001-08-14 | 2005-06-13 | 메디포스트(주) | Composition for treatment of articular cartilage damage |
DE10203644A1 (en) * | 2002-01-30 | 2003-08-07 | Fraunhofer Ges Forschung | Cryopreservation on textile fabrics |
US7736892B2 (en) | 2002-02-25 | 2010-06-15 | Kansas State University Research Foundation | Cultures, products and methods using umbilical cord matrix cells |
US20030161818A1 (en) * | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
US20040254640A1 (en) * | 2002-03-01 | 2004-12-16 | Children's Medical Center Corporation | Needle punched textile for use in growing anatomical elements |
AU2003253015A1 (en) * | 2002-06-20 | 2004-01-06 | Bionethos Holding Gmbh | Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
WO2004017972A1 (en) * | 2002-08-23 | 2004-03-04 | Law Peter K | Biologic skin repair and enhancement |
EP1551426B1 (en) * | 2002-10-07 | 2014-06-25 | ZymoGenetics, Inc. | Methods of administering fgf18 |
KR100539371B1 (en) * | 2002-10-21 | 2005-12-27 | 메디칸(주) | In vitro cultured human preadipocyte for human soft tissue volume replacement with injectable material as a scaffold |
US20040115804A1 (en) * | 2002-12-13 | 2004-06-17 | Yu-Show Fu | Cell system for generating somatic cells |
US20040127402A1 (en) * | 2002-12-27 | 2004-07-01 | Vad Vijay B. | Injectible composition and method for treating degenerative animal joints |
DE602004028803D1 (en) * | 2003-02-11 | 2010-10-07 | John E Davies | PRECURSOR CELLS FROM THE WHARTON SULCE OF HUMAN NECK LOCKS |
US8491883B2 (en) * | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
WO2005001081A1 (en) * | 2003-06-27 | 2005-01-06 | UNIVERSITé LAVAL | Method of isolating cells from umbilical cord |
US7875272B2 (en) * | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
EP1641913B1 (en) * | 2003-06-27 | 2016-01-06 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
WO2006071794A2 (en) * | 2004-12-23 | 2006-07-06 | Ethicon Incorporated | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
EP1678295B1 (en) | 2003-10-08 | 2013-03-06 | Vet-Stem Inc | Methods of preparing and using stem cell compositions and kits comprising the same |
EP2338442B1 (en) | 2003-12-11 | 2013-01-30 | Isto Technologies Inc. | Particulate cartilage system |
JP2005176663A (en) * | 2003-12-17 | 2005-07-07 | Ikushu Fu | Cell line for producing somatic cell |
EP2597149A1 (en) * | 2004-08-16 | 2013-05-29 | CellResearch Corporation Pte Ltd | Isolation, cultivation and uses of stem/progenitor cells |
US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
US20060166361A1 (en) * | 2004-12-21 | 2006-07-27 | Agnieszka Seyda | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
WO2006101548A2 (en) * | 2004-12-21 | 2006-09-28 | Ethicon, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same |
US20060153815A1 (en) * | 2004-12-21 | 2006-07-13 | Agnieszka Seyda | Tissue engineering devices for the repair and regeneration of tissue |
WO2006071773A2 (en) * | 2004-12-23 | 2006-07-06 | Ethicon Incoporated | Treatment of osteochondral diseases using postpartum-derived cells and products thereof |
WO2006071778A2 (en) | 2004-12-23 | 2006-07-06 | Ethicon Incorporated | Treatment of parkinson's disease and related disorders using postpartum derived cells |
EP1831355A2 (en) * | 2004-12-23 | 2007-09-12 | Ethicon, Inc. | Soft tissue repair and regeneration using postpartum-derived cells and cell products |
GB0511723D0 (en) * | 2005-06-09 | 2005-07-13 | Smith & Nephew | Placental stem cells |
US8480757B2 (en) | 2005-08-26 | 2013-07-09 | Zimmer, Inc. | Implants and methods for repair, replacement and treatment of disease |
NZ612132A (en) | 2005-10-13 | 2015-01-30 | Anthrogenesis Corp | Immunomodulation using placental stem cells |
CN103555655B (en) | 2005-10-21 | 2018-02-27 | 细胞研究私人有限公司 | The application of ancestral cells and its cell of differentiation is separated and cultivated from umbilical cord amniotic membrane |
WO2007070870A1 (en) * | 2005-12-16 | 2007-06-21 | Ethicon, Inc. | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
JP5179376B2 (en) * | 2005-12-19 | 2013-04-10 | エシコン・インコーポレイテッド | In vitro growth of postpartum-extracted cells in roller bottles |
CA2634820C (en) | 2005-12-22 | 2021-05-25 | Jane Ennis | Viable cells from frozen umbilical cord tissue |
SG170789A1 (en) * | 2005-12-28 | 2011-05-30 | Ethicon Inc | Treatment of peripheral vascular disease using postpartum-derived cells |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
EP1976978A2 (en) | 2005-12-29 | 2008-10-08 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
CN108559725A (en) | 2005-12-29 | 2018-09-21 | 人类起源公司 | placental stem cell populations |
US8157774B1 (en) | 2006-03-16 | 2012-04-17 | Deka Products Limited Partnership | Apparatus for stem cell collection and methods thereof |
PL2029149T3 (en) * | 2006-05-05 | 2017-12-29 | John E. Davies | Immune privileged and modulatory progenitor cells |
AU2007258514A1 (en) * | 2006-06-09 | 2007-12-21 | Anthrogenesis Corporation | Placental niche and use thereof to culture stem cells |
US20080003205A1 (en) * | 2006-06-26 | 2008-01-03 | University Of Massachusetts | Tympanic Membrane Repair Constructs |
CN104099290A (en) | 2006-10-23 | 2014-10-15 | 人类起源公司 | Methods and compositions for treatment of bone defects with placental cell populations |
ES2524443T3 (en) | 2006-11-13 | 2014-12-09 | DePuy Synthes Products, LLC | In vitro expansion of postpartum cells using microcarriers |
US20080132803A1 (en) * | 2006-11-30 | 2008-06-05 | Hyman Friedlander | Method and system for doing business by mining the placental-chord complex |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
EP2119767B1 (en) * | 2007-01-23 | 2016-01-20 | Yokohama City University | Method for preparation of cartilage cell |
EP3103462A1 (en) | 2007-02-12 | 2016-12-14 | Anthrogenesis Corporation | Treatment of inflammatory diseases using placental stem cells |
WO2008116160A1 (en) * | 2007-03-22 | 2008-09-25 | Kansas State University Research Foundation | Use of umbilical cord matrix cells |
WO2008128075A1 (en) | 2007-04-12 | 2008-10-23 | Isto Technologies, Inc. | Compositions and methods for tissue repair |
WO2008137115A1 (en) | 2007-05-03 | 2008-11-13 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
US9744043B2 (en) | 2007-07-16 | 2017-08-29 | Lifenet Health | Crafting of cartilage |
KR20190132556A (en) | 2007-09-28 | 2019-11-27 | 안트로제네시스 코포레이션 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
WO2009046335A1 (en) * | 2007-10-05 | 2009-04-09 | Ethicon, Incorporated | Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
US8236538B2 (en) | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
JP5773366B2 (en) | 2008-04-21 | 2015-09-02 | ティシュー リジェネレイション セラピューティックス、インコーポレイテッド | Human umbilical cord perivascular cells genetically modified for prevention or treatment of biological or chemical agents |
EP2291514B1 (en) | 2008-05-22 | 2020-12-23 | Vesta Therapeutics, Inc. | Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells |
US20090317448A1 (en) * | 2008-06-18 | 2009-12-24 | University Of Massachusetts | Tympanic membrane patch |
NZ591294A (en) | 2008-08-20 | 2012-10-26 | Anthrogenesis Corp | Treatment of stroke using isolated placental cells |
MX339624B (en) | 2008-08-20 | 2016-06-02 | Anthrogenesis Corp | Improved cell composition and methods of making the same. |
AU2009283161A1 (en) | 2008-08-22 | 2010-02-25 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
JP5702723B2 (en) | 2008-09-04 | 2015-04-15 | ザ ジェネラル ホスピタル コーポレイション | Hydrogels for strengthening and repairing vocal cords and soft tissues |
AU2008362567B2 (en) * | 2008-10-10 | 2015-11-12 | Histocell S.L. | New biomaterial based on wharton's jelly from the human umbilical cord |
JP5869342B2 (en) | 2008-11-19 | 2016-02-24 | アンスロジェネシス コーポレーション | Amnion-derived adherent cells |
US11248211B2 (en) * | 2008-11-25 | 2022-02-15 | Kolon Tissuegene, Inc. | Primed cell therapy |
US10179900B2 (en) * | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
CN102387807A (en) | 2008-12-19 | 2012-03-21 | 先进科技及再生医学有限责任公司 | Treatment of lung and pulmonary diseases and disorders |
US8722034B2 (en) * | 2009-03-26 | 2014-05-13 | Depuy Synthes Products Llc | hUTC as therapy for Alzheimer's disease |
CA2787992A1 (en) | 2010-01-26 | 2011-08-04 | Anthrogenesis Corporation | Treatment of bone-related cancers using placental stem cells |
US9198568B2 (en) | 2010-03-04 | 2015-12-01 | The General Hospital Corporation | Methods and systems of matching voice deficits with a tunable mucosal implant to restore and enhance individualized human sound and voice production |
US10226480B2 (en) * | 2010-03-30 | 2019-03-12 | Histocell, S.L. | Biomaterial from Wharton's jelly umbilical cord |
TW201703777A (en) | 2010-04-07 | 2017-02-01 | 安瑟吉納西斯公司 | Angiogenesis using placental stem cells |
US8562973B2 (en) | 2010-04-08 | 2013-10-22 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
PL2576768T3 (en) | 2010-06-01 | 2017-10-31 | Auxocell Laboratories Inc | Native wharton's jelly stem cells and their purification |
MX342995B (en) | 2010-07-13 | 2016-10-21 | Anthrogenesis Corp | Methods of generating natural killer cells. |
JP2012031127A (en) * | 2010-08-03 | 2012-02-16 | Nagoya Univ | Composition including umbilical cord matrix stromal cell |
AU2011352036A1 (en) | 2010-12-31 | 2013-07-18 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
CN113559126A (en) | 2011-06-01 | 2021-10-29 | 人类起源公司 | Treatment of pain using placental stem cells |
US9925221B2 (en) | 2011-09-09 | 2018-03-27 | Celularity, Inc. | Treatment of amyotrophic lateral sclerosis using placental stem cells |
JP6301263B2 (en) | 2011-12-23 | 2018-03-28 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | Detection of human umbilical cord tissue-derived cells |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
US9763983B2 (en) | 2013-02-05 | 2017-09-19 | Anthrogenesis Corporation | Natural killer cells from placenta |
AU2015287920A1 (en) * | 2014-07-08 | 2017-01-19 | Mimedx Group, Inc. | Micronized wharton's jelly |
TWI566774B (en) * | 2014-10-06 | 2017-01-21 | 佛教慈濟醫療財團法人花蓮慈濟醫院 | Composition for treatment of joint disease and method thereof |
US10542743B2 (en) | 2015-01-05 | 2020-01-28 | Hygieia Therapeutics Sdn Bhd | Isolation, expansion and characterization of wharton's jelly mesenchymal stem cells |
EP3423119A4 (en) | 2016-03-04 | 2020-02-19 | The Board of Regents of The University of Texas System | Devices and methods for umbilical cord processing |
US11723635B2 (en) | 2017-09-05 | 2023-08-15 | The Board Of Regents Of The University Of Texas System | Devices and methods for umbilical cord processing |
US20200339947A1 (en) | 2017-12-22 | 2020-10-29 | Chiesi Farmaceutici S.P.A. | Mesenchymal stromal cells and methods for obtaining mesenchymal stromal cells from umbilical cord |
US10961502B2 (en) * | 2018-03-12 | 2021-03-30 | P.E. Asia Biomedicine Co., Ltd. | Method for preparing collagen having regeneration and repair effects from Wharton's Jelly mesenchymal stem cells |
KR102110252B1 (en) * | 2018-05-29 | 2020-05-14 | 한국과학기술연구원 | Culturing device for cell under compressed circumstance and culturing method for the same |
WO2021003254A1 (en) * | 2019-07-01 | 2021-01-07 | Auxocell Laboratories, Inc. | Cryopreservation medium comprising a tissue extract |
WO2024024708A1 (en) * | 2022-07-26 | 2024-02-01 | 国立大学法人大阪大学 | Composition for cartilage repair and method for manufacturing same |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4352883A (en) * | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
IL68218A (en) * | 1983-03-23 | 1985-12-31 | Univ Ramot | Compositions for cartilage repair comprising embryonal chondrocytes |
US4609551A (en) * | 1984-03-20 | 1986-09-02 | Arnold Caplan | Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites |
US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US5041138A (en) * | 1986-11-20 | 1991-08-20 | Massachusetts Institute Of Technology | Neomorphogenesis of cartilage in vivo from cell culture |
US4846835A (en) * | 1987-06-15 | 1989-07-11 | Grande Daniel A | Technique for healing lesions in cartilage |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5226914A (en) * | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
-
1996
- 1996-10-23 US US08/735,620 patent/US5919702A/en not_active Expired - Lifetime
-
1997
- 1997-10-23 EP EP97912786A patent/EP0939803A1/en not_active Withdrawn
- 1997-10-23 AU AU49888/97A patent/AU731827B2/en not_active Expired
- 1997-10-23 KR KR1019990703506A patent/KR20000052709A/en not_active Application Discontinuation
- 1997-10-23 CA CA002269121A patent/CA2269121A1/en not_active Abandoned
- 1997-10-23 WO PCT/US1997/018862 patent/WO1998017791A1/en not_active Application Discontinuation
- 1997-10-23 JP JP10519528A patent/JP2001502905A/en active Pending
- 1997-10-23 NZ NZ335531A patent/NZ335531A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1998017791A1 (en) | 1998-04-30 |
JP2001502905A (en) | 2001-03-06 |
AU731827B2 (en) | 2001-04-05 |
AU4988897A (en) | 1998-05-15 |
EP0939803A1 (en) | 1999-09-08 |
US5919702A (en) | 1999-07-06 |
CA2269121A1 (en) | 1998-04-30 |
KR20000052709A (en) | 2000-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ335531A (en) | Composition and methods of producing human cartilage tissue | |
IL170221A (en) | Progenitor cells from wharton's jelly of human umbilical cord and methods of obtaining and utilizing same | |
IL160188A0 (en) | Materials and methods to promote repair of nerve tissue | |
DE69724275D1 (en) | BIOPOLYMER FOAMS FOR TISSUE RENEWAL AND RECONSTRUCTION | |
AU8476698A (en) | Human mesenchymal stem cells from peripheral blood | |
AU2155795A (en) | Alphavirus cdna vectors | |
BR9910251A (en) | Hematopoietic stimulation | |
WO2004009767A3 (en) | Cell therapy for regeneration | |
WO2002036751A3 (en) | Human cord blood derived unrestricted somatic stem cells (ussc) | |
AU2515197A (en) | The use of dna sequences for male sterility in transgenic plants | |
BR0210599A (en) | Use of carbon monoxide, method for maintaining an animal cell in vitro, article of manufacture as well as sterile cell medium | |
MXPA03006771A (en) | Modified antibodies and methods of use. | |
MY140581A (en) | Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin | |
DE69527626D1 (en) | METHODS AND AGENTS FOR THE PRODUCTION OF HYALURONIC ACID | |
TW200516149A (en) | Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair | |
MX348062B (en) | Proteoglycan degrading mutants for treatment of cns. | |
HK1087042A1 (en) | New use of dextran sulfate | |
ATE350474T1 (en) | BPC-1: A SECRETED BRAIN-SPECIFIC PROTEIN EXPRESSED AND SECRETED BY PROSTATE AND BLADDER CANCER CELLS | |
ES2151607T3 (en) | GROWTH AND DIFFERENTIATION FACTOR 12. | |
WO2001094541A3 (en) | Human mesenchymal progenitor cell | |
WO2001068828A3 (en) | Compositions and methods for regulated protein expression in gut | |
WO2002098361A3 (en) | T cell induced tissue repair and regeneration | |
WO2003029432A3 (en) | Human mesenchymal progenitor cell | |
IL131478A0 (en) | Methods for treatment of scar tissue | |
DE69737597D1 (en) | VECTORS FOR INHIBITING VIRAL AND TUMOR GROWTH |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) | ||
ASS | Change of ownership |
Owner name: T. J. SMITH AND NEPHEW LIMITED, GB Free format text: OLD OWNER(S): ADVANCED TISSUE SCIENCES, INC. |